▸ Strategic, results-driven C-suite executive with significant (18+ years) experience in the biotechnology and pharmaceutical industries. ▸ Extensive knowledge across diverse geographical regions and therapeutic areas. ▸ A proven history of successful strategic product launches, P&L management, and development of product pipelines. ▸ Recognized for an ability to combine a deep understanding of international market dynamics with a passion for innovation and growth. ▸ Excelling in strategically positioning biotechnology companies for long-term success, cultivating high-performing senior global teams, and meeting corporate objectives.✦ Key Highlights ✦▸ Expert in in-line and pipeline strategic development, P&L management, product planning, and multiple global product launches in rare disease, central nervous system (CNS) diseases, oncology and dermatology.▸ Drove double-digit YOY revenue growth across a portfolio of assets by employing a data-driven approach.▸ Led global teams across the United States, Europe, Latin America, and Asia Pacific, while driving geographic expansion. ▸ Built and developed high-performing teams to achieve corporate goals across both in-line and pipeline portfolios. • Success in leading business development (both in-licensing and out-licensing) and investor relations including capital raising✦ Areas of Experience ✦▸ Transformation and Change▸ Strategic Planning▸ Pricing and Reimbursement▸ Global Leadership▸ Investor Relations▸ Operations Management▸ Customer Engagement▸ Market Analysis▸ Business Development▸ Relationship Management▸ Regulatory Compliance▸ Brand Management▸ Sales and Marketing▸ Consumer Insights▸ Financial Acumen▸ Corporate Decision Making▸ Value and Access